The World Health Organisation (WHO) on Tuesday informed that the decision on Emergency Use Listing (EUL) authorisation of Bharat Biotech’s Covid-19 vaccine 'Covaxin' will be finalised next week.
The World Health Organisation is still reviewing data about Russia's Sputnik V vaccine as part of hopes that it can be approved by the UN health agency for emergency use against coronavirus, but said Tuesday that no decision is imminent.
Speaking on the issue Guleria said, "We are hopeful that now with all the data in and studies having been done it should happen soon rather than happening late."
Globally, the numbers of weekly COVID-19 cases and deaths continued to decline, WHO said.
Bharat Biotech had submitted EOI (Expression of Interest) on April 19 for its vaccine.
Discussing the role of booster doses to tackle waning immunity, Singh pointed out that cases and deaths in all countries are predominantly being driven by unvaccinated people.
Bharat Biotech has already completed the Phase 2/3 trials of Covaxin for use in children under 18 years of age.
A WHO-led team of scientists that travelled to China in early 2021 to investigate the origins of the virus struggled to get a clear picture of what research China was conducting beforehand, faced constraints during its visit.
The latest guidance adds to previous recommendations for the use of interleukin-6 receptor blockers and systemic corticosteroids for patients with severe or critical COVID-19.
India on Monday said that it will resume export of surplus COVID-19 vaccines in the fourth quarter of 2021 under the "Vaccine Maitri" programme and to meet its commitment to the Covax global pool
WHO Director-General Tedros Adhanom Ghebreyesus also said he was “appalled” after hearing comments Tuesday from a top association of pharmaceutical manufacturers that vaccine supplies are high enough to allow for both booster shots for people in well-supplied countries and first jabs in poorer countries that face shortages. He said that's already been the case.
The new variant 'Mu' has mutations that indicate a risk of resistance to vaccines and stressed that further studies were needed to better understand it, said WHO.
WHO and Unicef directs all schools that are reopening to vaccinate teachers and students against Covid-19 to keep schools safe.
UNHCR, the UN refugee agency, has expressed concern about the prevailing humanitarian needs within Afghanistan and urged for continuous support to ensure necessary assistance in the country.
"We believe clearly that the data does not indicate that boosters are needed," Swaminathan said at a news conference in Geneva. She expressed more understanding for a recent U.S. decision to administer boosters to people with weaker immune systems.
The drugs -- artesunate, imatinib, and infliximab -- were selected by an independent expert panel for their potential in reducing the risk of death in hospitalised Covid-19 patients, the WHO said in a statement.
The Wuhan branch of the Chinese Center for Disease Control and Prevention was handling coronaviruses “without potentially having the same level of expertise or safety or who knows,” Peter Ben Embarek said during a conference call in January, according to footage shown by TV2.
The Marburg virus belongs to the same family as Ebola, and previously outbreaks have erupted elsewhere across Africa in Angola, Congo, Kenya, South Africa and Uganda.
According to the new evidence, scientists at the WIV have been able to genetically modify coronaviruses without leaving a trace of that modification since 2005.
The UN health agency said Wednesday infections have been increasing for more than a month, although the worldwide number of deaths dropped by about 8%.
Top News
Latest News
